Entero Healthcare Stock Surges on Prashant Jain’s 3P Investment Stake

Entero Healthcare Solutions stock surged 5.31% to Rs 1,611.10 on August 24, 2026, following 3P Investment Managers’ acquisition of a 2.5% stake in the company. This significant move by veteran fund manager Prashant Jain’s firm quickly impacted market sentiment.

Strategic Investment Details

The acquisition involved two funds under 3P Investment Managers, namely 3P India Equity Fund 1M and 3P India Equity Fund 1. These funds collectively purchased a substantial block of shares from the Prasid Uno Family Trust.

• Shares Acquired: 1,088,500 shares
• Price Per Share: Rs 1,377.80
• Total Investment: Approximately Rs 150.04 crore
• Stake Percentage: 2.5% of Entero Healthcare’s total paid-up equity capital

As of June 2026, Surbhi Singh, representing the Prasid Uno Family Trust, held 4,550,320 shares, constituting a 10.45% stake in Entero Healthcare.

Recent Stock Performance

The company’s stock has demonstrated robust performance across several recent trading periods, reflecting increasing investor confidence. This latest stake acquisition further bolsters its market position.

• Four Consecutive Sessions: Gained 16.17%
• Past Month: Increased by 31.11%
• Last Three Months: Rose by 19.47%
• Annually: Saw a significant rise of 31.57%

Operational and Financial Highlights

Entero Healthcare Solutions specializes in the distribution and marketing of pharmaceutical and surgical products, alongside providing related services. This core business underpins its recent financial achievements.

The company reported strong financial results for the first quarter ending June 2026. Consolidated net profit and sales both saw substantial year-over-year increases.

• Q1 June 2026 Consolidated Net Profit: Increased 37.27% to Rs 38.16 crore (compared to Q1 2025)
• Q1 June 2026 Net Sales: Rose 38.23% to Rs 1,940.50 crore